Long-term treatment with SMS 201–995 in resistant acromegaly: Effectiveness of high doses and continuous subcutaneous infusion
- 1 January 1991
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 69 (2) , 83-90
- https://doi.org/10.1007/bf01666821
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- CONTINUOUS INFUSION OF OCTREOTIDE IN ACROMEGALYThe Lancet, 1989
- Comparison of the Effectiveness of 2-HourlyVersus8-Hourly Subcutaneous Injections of a Somatostatin Analog (SMS 201-995) in the Treatment of AcromegalyJournal of Clinical Endocrinology & Metabolism, 1989
- THERAPY OF ACROMEGALY WITH SANDOSTATIN: THE PREDICTIVE VALUE OF AN ACUTE TEST, THE VALUE OF SERUM SOMATOMEDIN‐C MEASUREMENTS IN DOSE ADJUSTMENT AND THE DEFINITION OF A BIOCHEMICAL ‘CURE’Clinical Endocrinology, 1988
- EFFECTIVE LONG-TERM TREATMENT OF ACROMEGALY WITH A LONG-ACTING SOMATOSTATIN ANALOGUE (SMS 201–995)Clinical Endocrinology, 1987
- Treatment of Resistant Acromegaly with a Long-Acting Somatostatin Analogue (SMS 201-995)Annals of Internal Medicine, 1986
- Secretory patterns of growth hormone during basal periods in manMetabolism, 1986
- THE SENSITIVITY OF GROWTH HORMONE AND PROLACTIN SECRETION TO THE SOMATOSTATIN ANALOGUE SMS 201–995 IN PATIENTS WITH PROLACTINOMAS AND ACROMEGALYClinical Endocrinology, 1986
- Long-Term Treatment of Acromegaly with the Somatostatin Analogue SMS 201–995New England Journal of Medicine, 1985
- Transsphenoidal surgery for acromegaly—long-term results in 100 patientsSurgical Neurology, 1985
- LONG-ACTING AND SELECTIVE SUPPRESSION OF GROWTH HORMONE SECRETION BY SOMATOSTATIN ANALOGUE SMS 201-995 IN ACROMEGALYThe Lancet, 1984